Lymphoma

I was told that after five years in remission, my cancer would be behind me. However, I was not told what life would be like after that milestone.

Having a check-up appointment without receiving any type of scan is good, but also scares me.

From the lead singer of Heart’s cancer diagnosis and postponing their tour to Dick Vitale’s upcoming cancer surgery, here’s what’s going on in the cancer space this week.

More frequent immunoglobulin G testing was associated with a decreased risk of severe infections in patients with CLL and non-Hodgkin lymphoma.

Sometimes, laughter really is the best medicine, so I tried to maintain a sense of humor through my cancer treatments.

Although there are still cancer drugs in short supply, the chief medical officer at the NCCN explained that most patients will not get suboptimal care.

From Judge Frank Caprio opening up about his diagnosis of pancreatic cancer and treatment to an “Ink Master” star dying from testicular cancer, here’s what’s going on in the oncology space this week.

The Food and Drug Administration approved Epkinly, a bispecific T-cell engager, for certain patients with follicular lymphoma.

In children with T-lymphoblastic lymphoma, having an MRD status of less than 0.1% may lead to more time without their cancer worsening or coming back.

My oncologist said that having a supportive community during cancer is just as important as treatment and I could not agree more — it makes me thankful.

Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma tended to be more likely to stay on treatment and experience fewer heart toxicities with Calquence or Brukinsa.

Staying positive while receiving cancer treatment for non-Hodgkin lymphoma helped me feel grateful for happy moments.

My experience with non-Hodgkin lymphoma taught me to be grateful for the people I love and who love me.

When my sister experienced nausea and vomiting during her Hodgkin lymphoma treatment, we tried alternatives that seemed to help.

When I came across an article with advice written by an oncologist for patients, I thought about his advice carefully.

Having a support system of loved ones truly helps during cancer.

An Adcetris-based treatment regimen improved progression-free survival and was more tolerable for patients with classical Hodgkin lymphoma.

When a group of people told me my non-Hodgkin lymphoma cure was a miracle, I realized it was only made possible because of health care professionals.

The CAR-T cell therapy, Breyanzi, has received FDA approval for relapsed or refractory mantle cell lymphoma.

As someone with follicular lymphoma, I joined a cancer advocacy group, but it wasn't what I was expecting.

Here’s a look at therapies the FDA approved in the blood cancer space over the last few months.

From Michael Richards revealing his prostate cancer diagnosis to MLB Hall-of-Famer Ryne Sandberg being cancer-free, here’s what’s happening in the oncology space this week.

My sister and I have learned to focus on the present day after a rollercoaster ride of remission, a cure and recurrence of stage 4 Hodgkin lymphoma.

These poems encapsulated my successful battle with stage 4 Hodgkin lymphoma.

The Food and Drug Administration approved Breyanzi for patients with pretreated, relapsed or refractory follicular lymphoma.

From Ian Gelder of “Game of Thrones” dying of cancer to Hank Green’s upcoming cancer comedy series, here’s what’s happening in the oncology space this week.

Patients with TP53/PPM1D mutations in their stem cell product had an increased risk of myeloid neoplasms in patients with Hodgkin lymphoma undergoing autologous stem cell transplant.

When I received a diagnosis of colon cancer, my priorities had to change drastically.

From the death of author Paul Auster and musician Duane Eddy to King Charles’ visit to a cancer hospital, here’s what’s happening in the cancer space this week.

Adding Calquence to standard-of-care chemoimmunotherapy improved progression-free survival in patients with previously untreated mantle cell lymphoma.